ANNUAL GENERAL MEETING OF PROACT IT GROUP AB (publ)

Summary by AI BETAClose X

Proact IT Group AB has announced its Annual General Meeting will be held on May 5, 2026, where shareholders will vote on several key proposals including a dividend of SEK 2.60 per share for 2025, the re-election of the Board of Directors and Chair, and the introduction of a 2026 Performance Share Program for employees. The meeting will also consider authorising the Board to issue new shares, up to a 9% dilution, and to acquire and dispose of own shares, with a proposed reduction of share capital by SEK 568,132 through the cancellation of 1,450,000 repurchased shares, followed by a bonus issue to restore capital. The total number of shares and votes is 27,101,658, with the company holding 1,845,745 treasury shares.

Disclaimer*

The shareholders of Proact IT Group AB (publ), 556494-3446, are hereby invited to attend the Annual General Meeting on Tuesday 5 May 2026 at 4.00 pm. The Annual General Meeting will be held at Meeting:Labs, Gate:01, Frösundaviks Allé 1, Solna.

In accordance with the provisions of Chapter 7, Section 4a of the Swedish Companies Act and the company’s Articles of Association, the Board of Directors has resolved that shareholders shall have the opportunity to exercise their voting rights by postal vote prior to the Annual General Meeting. Shareholders may therefore choose to attend the Annual General Meeting in person, by proxy or by postal vote.

 

Registration and notification
Shareholders wishing to attend the Annual General Meeting in person must

  • be entered in the register of shareholders maintained by Euroclear Sweden AB on Friday 24 April 2026,
  • and notify the company of their intention to attend the meeting no later than Tuesday 28 April 2026, at the address Computershare AB, “Proact IT Group AB’s Annual General Meeting”, Box 149, 182 12 Danderyd, or by email to proxy@computershare.se.

Shareholders wishing to participate in the Annual General Meeting by postal vote must

  • be registered in the share register maintained by Euroclear Sweden AB on Friday 24 April 2026,
  • and no later than Tuesday 28 April 2026, register by casting their postal vote in accordance with the instructions under the heading ‘Postal voting’ below, so that the postal vote is received by Computershare no later than that date. 

For shareholders whose shares are held in a nominee account through a bank or other nominee, the following applies in order to be entitled to participate in the meeting. In addition to registering, such shareholders must re-register their shares in their own name so that the shareholder is registered in the share register maintained by Euroclear Sweden AB as at the record date, Friday 24 April 2026. Such re-registration may be temporary (so-called voting rights registration). Shareholders wishing to register their shares in their own name must, in accordance with the procedures of the relevant custodian, request that the custodian carry out such registration. Voting rights registration requested by shareholders in such a manner that the registration has been completed by the custodian no later than Tuesday 28 April 2026 will be taken into account when compiling the share register.

Postal voting
The Board of Directors has resolved that shareholders shall also be able to exercise their voting rights by postal vote in accordance with the provisions of Proact’s Articles of Association. A specific form must be used for postal voting. The postal voting form is available on the company’s website, www.proact.eu, and will be sent to shareholders who request it and provide their postal address. Completed and signed postal voting forms may be sent by post to Computershare AB, “Proact IT Group AB’s Annual General Meeting”, Box 149, 182 12 Danderyd, or by email to proxy@computershare.se. Completed forms must be received by Computershare no later than 28 April 2026. Shareholders who are natural persons may also cast postal votes electronically by verifying their identity using BankID via a link provided on the company’s website www.proact.eu. Such electronic votes must be cast no later than 28 April 2026.

Shareholders must not include any special instructions or conditions with their postal vote. If this occurs, the entire postal vote will be invalid. Further instructions and conditions are set out in the postal voting form and on the company’s website www.proact.eu.
 
Proxies
If a shareholder intends to be represented by a proxy at the Annual General Meeting, a written and dated proxy form signed by the shareholder must be attached to the notice of attendance. If a shareholder votes by post through a proxy, a written and dated proxy form signed by the shareholder must be attached to the postal voting form. If the shareholder is a legal entity, a certificate of registration or other document of authority must be attached to the notification or form. Proxy forms are available on the company’s website www.proact.eu and will be sent to shareholders who so request and provide their postal address.

The total number of shares and votes in the company at the time of the notice of meeting is 27,101,658, of which 1,845,745 are held by the company.

Proposed agenda

  1. Opening of the meeting
  2. Election of the Chairman of the Meeting
  3. Preparation and approval of the voting register
  4. Approval of the agenda
  5. Election of at least one person to verify the minutes
  6. Determination of whether the meeting has been duly convened
  7. Presentation of the annual report and the auditor’s report, as well as the consolidated financial statements and the consolidated auditor’s report, and a presentation by the Chief Executive Officer in connection therewith
  8. Resolution on the adoption of the profit and loss account and balance sheet, as well as the consolidated profit and loss account and consolidated balance sheet
  9. Resolution on the allocation of the company’s profit in accordance with the adopted balance sheet
  10. Resolution on the discharge from liability of the members of the Board of Directors and the Chief Executive Officer
  11. Determination of the number of Board members and deputy members, as well as auditors
  12. Approval of remuneration for the Board and the auditors
  13. Election of the Board of Directors, the Chairman of the Board and the auditor
  14. Resolution on principles for the appointment of a nomination committee
  15. Resolution regarding approval of the remuneration report
  16. Decision on the 2026 performance share scheme
  17. Resolution on authorising the Board to decide on a new issue of shares
  18. Resolution regarding authorisation for the Board of Directors concerning the acquisition and disposal of the company’s own shares
  19. Resolution regarding a reduction in share capital (cancellation) and a bonus issue
  20. Closing of the AGM

This year’s Nomination Committee

The Nomination Committee for the 2026 Annual General Meeting consists of Katarina Berggren (Aktiebolaget Grenspecialisten), Niclas Röken (Alcur Fonder AB), Jesper Bergström (Handelsbanken Fonder) and Johannes Wingborg (Länsförsäkringar Fondförvaltning AB). Katarina Berggren was appointed by the Nomination Committee as its chair.


Election of the Chairperson at the Meeting (item 2)

The Nomination Committee proposes that Anna Söderblom be elected as Chair of the Annual General Meeting.


Preparation and approval of the voting register (item 3)

The voting list proposed for approval is the voting list drawn up by the Chair of the Annual General Meeting, based on the share register, registered and attending shareholders, proxies and assistants, as well as postal votes received.


Approval of the agenda (item 4)

It is proposed that the agenda included in this notice of the Annual General Meeting be approved as the agenda for the Annual General Meeting.


Determination of whether the meeting has been duly convened (item 6)

It is proposed that the meeting approve the convening of the Annual General Meeting.


Resolution on the allocation of the company’s profit in accordance with the adopted balance sheet (item 9)
The Board of Directors proposes a dividend of SEK 2.60 per share for the financial year 2025. The proposed record date for the dividend is 7 May 2026. If the Annual General Meeting resolves in accordance with the proposal, the dividend is expected to be distributed through Euroclear Sweden AB on 12 May 2026.

Determination of the number of Board members and deputies, as well as auditors (item 11)

The Nomination Committee proposes that the Board of Directors, for the period until the end of the next Annual General Meeting, shall consist of five members without deputies.


The Nomination Committee further proposes that one auditor, without deputies, be elected for the period until the end of the next Annual General Meeting.

Determination of remuneration for the Board and the auditors (item 12)

The Nomination Committee proposes that Board remuneration be set at SEK 2,415,000 for the period until the end of the next Annual General Meeting, of which the Chairman shall receive SEK 675,000 and the other members shall receive SEK 310,000 each. For committee work, a total remuneration of SEK 500,000 is proposed, to be allocated by the Board among the Board’s three committees.


The Nomination Committee proposes that remuneration to the auditor, for the period until the end of the next Annual General Meeting, be paid in accordance with the approved invoice.

Election of the Board of Directors, the Chairman of the Board and the auditor (item 13)
The Nomination Committee proposes the re-election of Board members Anna Söderblom, Martin Gren, Annikki Schaeferdiek, Erik Malmberg and Jon Risfelt for the period until the end of the next Annual General Meeting. In addition, it is proposed that Anna Söderblom be re-elected as Chair of the Board for the period until the end of the next Annual General Meeting.

The Nomination Committee proposes the re-appointment of Öhrlings PricewaterhouseCoopers AB as auditors for the period until the end of the next Annual General Meeting. Öhrlings PricewaterhouseCoopers AB has informed the Nomination Committee that the authorised public accountant Magnus Thorling will be the lead auditor if Öhrlings PricewaterhouseCoopers AB is appointed in accordance with the Nomination Committee’s proposal.

Resolution on principles for the appointment of the Nomination Committee (item 14)
The Nomination Committee proposes unchanged principles regarding the appointment of the Nomination Committee, namely that the company shall have a Nomination Committee, that no remuneration shall be paid to the members of the Nomination Committee, and that the Nomination Committee process shall otherwise be as follows.

  1. The Nomination Committee shall consist of four or, in the case specified in item 8 below, five members. The Nomination Committee is also entitled to co-opt the Chairman of the Board to attend the Nomination Committee’s meetings.
  2. Based on the shareholder statistics received by the company from Euroclear Sweden AB as at 30 September of each year and on other reliable information provided to the company at that time, the Chairman of the Board shall, without undue delay, contact the four largest shareholders in the company in terms of voting rights, whether directly registered or grouped by ownership, who have disclosed their identity, and offer each of them the opportunity to appoint a member of the Nomination Committee. If any of them declines the right to appoint a member or fails to respond to the request within a reasonable time (maximum five calendar days), the right to appoint such a member shall pass to the next largest shareholder in terms of voting rights, who does not already have the right to appoint a member of the Nomination Committee.
  3. The member of the Nomination Committee appointed by the largest shareholder in terms of voting rights shall be the chair of the Nomination Committee unless the Nomination Committee decides otherwise.
  4. The member of the Nomination Committee appointed by the largest shareholder in terms of voting rights shall have the casting vote.
  5. The Chairman of the Board shall convene the first meeting.
  6. The term of office as a member of the Nomination Committee shall continue until a new Nomination Committee has been appointed or in the cases specified in paragraph 8 below.
  7. The names of the members of the Nomination Committee shall be published as soon as the Nomination Committee has been appointed and no later than six months prior to the forthcoming Annual General Meeting.
  8. If a change occurs in the company’s ownership structure after 30 September but before the date falling two months prior to the forthcoming Annual General Meeting, and if a shareholder who, following this change, has become one of the four largest shareholders in the company in terms of voting rights submits a request to the chair of the Nomination Committee to be included in the Nomination Committee, such a shareholder shall be entitled either to appoint an additional member of the Nomination Committee or, if the Nomination Committee so decides, to appoint a member of the Nomination Committee to replace the member who, following the change in ownership, is the smallest shareholder in terms of voting rights and who has appointed a member of the Nomination Committee. In addition, a member appointed by a shareholder who, after 30 September, has sold more than half of their shareholding and who, as a result, no longer ranks among the ten largest shareholders in the company, is obliged to resign from the company’s Nomination Committee within two weeks of the date of the sale.
  9. If a member appointed by a shareholder resigns from the Nomination Committee during their term of office, or if a member is prevented from fulfilling their duties, the Chairman of the Board shall, without undue delay, request the shareholder who appointed the member to appoint a new member within a reasonable period of time. If the shareholder does not exercise the right to appoint a new member, the right to appoint such a member shall pass to the next largest shareholder in terms of voting rights, provided that shareholder has not already appointed or waived the right to appoint a member of the Nomination Committee.
  10. The Nomination Committee shall perform the duties that from time to time arise under the Swedish Code of Corporate Governance. The Nomination Committee’s remit includes, among other things, submitting proposals for (i) the Chairman of the Annual General Meeting, (ii) the Chairman of the Board and other Board members, (iii) fees and other remuneration for Board members’ duties, (iv) the appointment of auditors, (v) the remuneration of auditors, and (vi) the nomination committee process in general.
  11. The Nomination Committee shall be entitled to charge the company for costs attributable to the work of the Nomination Committee.

Resolution on the approval of the remuneration report (item 15)

The Board of Directors proposes that the Annual General Meeting resolve to approve the remuneration report.


Resolution regarding the 2026 Performance Share Program (item 16)
The Board of Directors proposes that the Annual General Meeting resolve to introduce a Performance Share Program 2026 (“Performance Share Program 2026”). The proposal is divided into four parts:

  1. Terms and conditions of the 2026 Performance Share Program.
  2. Hedging measures through the transfer of own shares
  3. Hedging measures through the conclusion of share swap agreements with third parties
  4. Other matters

(A) Terms and conditions of the 2026 Performance Share Program
A.1 Performance Share Program 2026 in summary

The 2026 Performance Share Program is aimed at current and future employees of the company and its subsidiaries with the aim of promoting long-term share ownership and strengthening the ability to recruit, retain and motivate employees. The plan largely follows the structure approved at the 2025 Annual General Meeting.


Participation in the programme requires a personal investment in Proact shares. Following the Vesting Period (defined below) of approximately three years, participants may be allocated Proact shares free of charge provided that:

  • The participant has remained employed by the company or its subsidiaries throughout the Vesting Period
  • The investment in Proact shares has been maintained in full throughout the Vesting Period
  • Performance targets linked to the company’s earnings per share and/or turnover have been met
  • The threshold for the company’s net debt divided by EBITDA (“Net Debt-to-EBITDA”) has not been exceeded, and
  • The threshold value for earnings per share has been achieved. 

A.2 Participants in the 2026 Performance Share Program
The scheme covers a maximum of 20 current and future employees, divided into:

  • Category A: Chief Executive Officer (1 person)
  • Category B: Group management (up to 7 persons)
  • Category C: other key employees (up to 12 persons)

New employees may be offered participation after the initial application period, but no later than 31 December 2026. For such participants, the vesting period may be shorter than three years.

A.3 The private investment and allocation of share rights

To participate in the 2026 Performance Share Program, participants must acquire and lock up Proact shares under the 2026 Performance Share Program (“Investment Shares”) as follows:

  • All categories: at least 500 shares
  • Category A: a maximum of 4,000 shares
  • Category B: maximum 2,000 shares
  • Category C: a maximum of 1,250 shares

If the participant holds inside information and is therefore prevented from acquiring shares in connection with enrolment in the 2026 Performance Share Program, the acquisition of shares shall take place as soon as possible after the restriction has ceased and acquisition is permitted, but no later than 31 December 2026.
 
For each Investment Share, the participant receives seven (7) share rights. Allocation of shares will take place during a limited period following the end of the Vesting Period, which runs from the date on which the agreement to participate in the 2026 Performance Share Program is entered into until the date of publication of Proact’s interim report for the first quarter of 2029 (“the Vesting Period”).

If the participant holds inside information and is therefore prevented from receiving shares at that time, the allocation of Proact shares shall take place as soon as possible after the impediment has ceased.

A.4 Terms and conditions for share rights

The following conditions apply to share rights:

  • Share rights are allocated free of charge.
  • Participants are not entitled to transfer, pledge, dispose of or exercise any shareholder rights in respect of the share rights.
  • Allocation is subject to continued employment and holding of Investment Shares throughout the vesting period (with certain exceptions).
  • Allocation is subject to the fulfilment of performance targets and the financial threshold conditions set out above.
  • The Company will compensate participants if the Company’s dividend payments exceed the upper range set out in the Company’s dividend policy.
  • The maximum value (including any compensation for dividends paid) that a participant may receive per share right is capped. This value corresponds to three times the volume-weighted average price of the Proact share during the first ten trading days following 5 May 2026. If the value of the Proact share, at the time of allocation, exceeds the maximum value, the number of shares to which each share right entitles the holder will be reduced to achieve the aforementioned limit. Allocation can only be made in whole Proact shares, which is why the number of Proact shares will be rounded down to the nearest whole Proact share.

A.5 Performance targets
The Performance Share Program has been designed to link remuneration to the company’s earnings and value growth, thereby creating long-term shareholder value.

Allocation is based on the achievement of two performance targets for the financial year 2028:

  • earnings per share
  • turnover

The targets are measured independently and weighted equally. Maximum allocation requires that the maximum level is achieved for both targets. No allocation will be made for a target if the minimum level is not achieved. The outcome is determined on a linear basis between the minimum and maximum levels.

Minimum and maximum levels, as well as the outcome, will be reported upon the programme’s conclusion and in the remuneration report for the 2029 Annual General Meeting.

In addition, Net Debt-to-EBITDA must not exceed the set threshold, and the threshold for earnings per share must be met. If these are not met, no award will be made regardless of target achievement.

A.6 Scope
A maximum of 231,000 shares may be allocated (approximately 0.85 per cent of outstanding shares and votes).
This number may be adjusted in the event of, for example, a bonus issue, a share split or a rights issue.

A.7 Structure and administration
The Board of Directors is responsible for the detailed design and implementation of the programme.
The Board should:

  • offer cash settlement or alternative incentive arrangements in certain jurisdictions where this is appropriate due to local regulations in those jurisdictions,
  • postpone the launch for administrative, market-related or regulatory reasons (in which case the term may be shorter),
  • adapt the programme in the event of major structural changes, such as the divestment or acquisition of major divisions, in which case the Board shall amend the performance targets in proportion to the change that has occurred so that the performance targets following the change are at least as challenging as they were prior to the change. A corresponding adjustment shall be made in the event of, for example, a bonus issue, share split or rights issue,
  • adjust the programme in the event of significant changes in the company or the market, including reducing or completely omitting the allocation,
  • assess whether the allocation is reasonable in relation to the company's results, position and development.

In the event that the Annual General Meeting does not resolve in accordance with point B by the required majority, hedging shall be affected through share swap agreements with third parties in accordance with point C below.

(B) Hedging measures through the transfer of own shares 

In order to implement the programme in a cost-effective and flexible manner, the Board proposes that the company’s obligations regarding the delivery of Proact shares be secured primarily through the transfer of Proact shares held by the company.


The Board proposes that, to ensure the delivery of shares, the company:

  • transfer a maximum of 231,000 treasury shares (subject to customary adjustments),
  • transfer shares free of charge at the time and on the terms on which participants are entitled to allocation.

The deviation from shareholders’ preferential rights is justified by the implementation of the programme. This is the Board’s preferred option.

(C) Hedging measures through the conclusion of share swap agreements with third parties
If the required majority is not achieved for point B, the company shall enter into share swap agreements with third parties, who, in their own name, acquire and transfer shares corresponding to the scope of the programme.
This solution is less cost-effective and is based on interest costs plus the company’s borrowing costs.

(D) Other matters relating to the 2026 Performance Share Program
D.1 Estimated costs and value of the 2026 Performance Share Program

The cost of the 2026 Performance Share Program, assuming (i) that all persons offered participation in the plan participate, (ii) that each participant acquires the maximum number of Investment Shares, (iii) that the performance targets are met by 50 per cent, (iv) the company has a staff turnover rate of 10 per cent among programme participants, (v) the share price increases by 10 per cent annually, and (vi) social security contributions amount to 25 per cent, the total estimated annual costs amount to approximately SEK 3.5 million, of which SEK 0.9 million constitutes social security contributions.


If 100 per cent of the targets are met, the total annual costs are estimated at approximately SEK 7.1 million, of which SEK 1.9 million represents social security contributions.

The cost of security measures is estimated at approximately SEK 150,000.

D.2 Impact on key performance indicators

The estimated annual cost of SEK 3.5 million corresponds, on a pro forma basis for 2025, to a negative impact of approximately 0.08 percentage points on Proact’s operating margin and a reduction in earnings per share of approximately SEK 0.10.
The Board of Directors considers that the programme’s positive effects outweigh the costs


D.3 Preparation of the proposal

The principles for the 2026 Performance Share Program have been drawn up by the company’s Board with the support of external advisers and following consultation with shareholders. Apart from the executives who prepared the matter in accordance with instructions from the Board, no employee who may be covered by the plan has participated in the drafting of the terms and conditions.


D.5 Other share-based incentive schemes

The company’s other share-based incentive schemes are described on page 92 of the company’s annual report for the financial year 2025.


D.6 Majority requirement

Resolutions in accordance with point A (including point C) above require that the resolution be supported by shareholders representing more than half of the votes cast at the Annual General Meeting.


Resolutions in accordance with item B above require that the resolution be supported by shareholders representing at least nine-tenths (9/10) of both the votes cast and the shares represented at the meeting.

Resolution to authorise the Board of Directors to decide on a new issue of shares (item 17)

The Board of Directors proposes that the Annual General Meeting resolve to authorise the Board of Directors to, with or without deviation from shareholders’ preferential rights, on one or more occasions, up to the time of the next Annual General Meeting, resolve on a new issue of a total of no more than 2,710,166 shares. This corresponds to a dilution effect of approximately 9 per cent of the share capital and votes if the authorisation is fully utilised as at the date of this notice. It is noted, however, that issues under the authorisation will be limited so that newly issued shares, together with any repurchased shares under the authorisation in item 18 below, may in total amount to a maximum of 10 per cent of the number of shares outstanding at any given time.


Resolutions regarding new issues, with or without deviation from shareholders’ preferential rights, may be made against cash payment and/or with provisions for non-cash consideration or set-off, or such that subscription may take place on other terms. Payment by set-off may, however, only take place in connection with corporate acquisitions. The Board of Directors may otherwise determine the terms and conditions for such a new issue.

The Board, or the person appointed by the Board, shall be authorised to make such minor adjustments to the resolution as may prove necessary in connection with the registration of the resolution with the Swedish Companies Registration Office.

Resolution on authorisation for the Board regarding the acquisition and transfer of the company’s own shares (item 18)
The Board of Directors proposes that the Annual General Meeting resolve to authorise the Board of Directors, during the period until the next Annual General Meeting, on one or more occasions, to decide on the acquisition and disposal of own shares as follows.

Shares in the company may only be acquired either on Nasdaq Stockholm (“the stock exchange”) or pursuant to a takeover offer to all of the company’s shareholders. Acquisitions may be made of no more than such a number of shares that the repurchased shares, together with any newly issued shares pursuant to the authorisation in paragraph 17 above, in total amount to no more than 10 per cent of the number of shares in the Company outstanding at any given time, and provided that, following the repurchase, there is still full coverage for the Company’s restricted equity. Acquisitions on the stock exchange may only be made at a price per share that falls within the price range registered at any given time. Acquisitions of shares through a tender offer to all the company’s shareholders may only be made at a price that, at the time of the tender offer, does not fall below the market value of the shares and that exceeds the market value by no more than 20 per cent. Payment for the shares shall be made in cash. The transfer of shares in the company may take place with a deviation from shareholders’ pre-emptive rights and with a provision that payment may be made in kind, i.e. by way of a contribution in kind or set-off. However, payment by set-off may only take place in connection with a business acquisition. The transfer may cover the entire number of own shares held by the company at any given time. The transfer may not take place on the stock exchange.

Resolution on a reduction of the share capital (cancellation) and a bonus issue (item 19)
The Board of Directors proposes that the Annual General Meeting resolve to reduce the share capital (cancellation) and to increase the share capital through a bonus issue. The proposal is divided into two parts:

  1. Resolution on a reduction of the share capital.
  2. Resolution regarding an increase in share capital through a bonus issue.

The Board’s proposals under items A and B are conditional upon one another, and therefore the proposals must be decided upon in a single resolution. A valid resolution requires that the resolution be supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting.

(A) Resolution on a reduction of the share capital

The company holds 1,845,745 of its own shares. The Board of Directors proposes that the Annual General Meeting resolve that the company’s share capital be reduced by SEK 568,132 through the cancellation of a total of 1,450,000 shares that the company has repurchased based on previous repurchase authorisations. The purpose of the reduction is to allocate funds to non-restricted equity. The reduction means that the company’s share capital will decrease from SEK 10,618,837 to SEK 10,050,705 and that the number of shares will decrease from 27,101,658 shares to 25,651,658 shares.
The resolution is conditional upon the Annual General Meeting resolving to increase the share capital through a bonus issue in accordance with point B below, and that the reduction in share capital and the bonus issue together do not result in a reduction in the company’s share capital.
The Board of Directors, or the person appointed by the Board, is authorised to make the minor adjustments required for the registration of the resolution with the Swedish Companies Registration Office.

(B) Resolution on an increase in share capital

The Board of Directors proposes that the Annual General Meeting resolve that the company’s share capital be increased by SEK 568,132 through a bonus issue without the issue of new shares, by transferring SEK 568,132 from non-restricted equity to the company’s share capital. The purpose of the bonus issue is to restore the share capital following the reduction of the share capital in accordance with item A above.


The resolution is conditional upon the Annual General Meeting resolving to reduce the share capital in accordance with item A above, and that the reduction of the share capital and the bonus issue together do not result in a reduction of the company’s share capital.

The Board of Directors, or the person appointed by the Board, is authorised to make the minor adjustments required for the registration of the resolution with the Swedish Companies Registration Office.

Documents and further information

Financial statements and the auditor’s report, the Board’s remuneration report, the Nomination Committee’s proposals and reasoned opinion, and other necessary documents will be made available at the company’s offices at Frösundaviks Allé 1, Solna, from 14 April 2026 at the latest. Copies of these documents will also be sent free of charge to shareholders who request them and provide their postal address. The documents are also available on the company’s website www.proact.eu.


At the Annual General Meeting, shareholders are entitled, if the Board of Directors considers that this can be done without material detriment to the company, to information regarding circumstances that may affect the assessment of a matter on the agenda, as well as circumstances that may affect the assessment of the financial situation of the company or its subsidiaries (i.e. the right to ask questions pursuant to Chapter 7, Section 32 of the Companies Act).

Processing of personal data
For information on how personal data is processed in connection with the Annual General Meeting, please visit https://www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf.

______________________

Stockholm, April 2026
Proact IT Group AB (publ)
The Board

UK 100

Latest directors dealings